Table 1

Clinical characteristics of all patients at baseline and follow-up

Baseline

Follow-up


Creatinine, ╬╝mol/L

92.3 (46.6)

81.6 (42.6)

Proteinuria, g/day

2.0 (1.8)

0.7 (0.8)

C3, g/L

0.53 (0.23)

0.80 (0.23)

C4, g/L

0.09 (0.06)

0.13 (0.07)

C1q

66.6% (41.0%)

75.2% (29.5%)

Anti-dsDNA-positivea

83%

44%

Glomerular filtration rate

80.7 (29.4)

88.6 (26.4)

U-erythrocytes > 1+

79%

46%

Renal histology, number

Class I

15

1

Class II

12

13

Class III

2

6

Class IV

6

3

Class III/V

12

Class V

Activity index

5.7 (3.1)

2.5 (2.3)

Chronicity index

1.8 (2.0)

2.3 (2.3)

Treatment, number

Cyclophosphamide

21

Mycophenolate mofetil

8

Rituximab

5

Azathioprin

1

BILAG renal index, number

A

32

2

B

3

18

C

7

D

8


Values are presented as mean (standard deviation) unless otherwise indicated. aAnti-double-stranded DNA (anti-dsDNA) raised to at least 1:25. BILAG, British Isles lupus assessment group.

Zickert et al. Arthritis Research & Therapy 2012 14:R36   doi:10.1186/ar3747

Open Data